cosmic-313: cabozantinib with nivolumab and ipilimumab in untreated arcc
Published 2 years ago • 246 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
4:01
cosmic-313: cabo nivo ipi in 1l advanced rcc of imdc intermediate or poor risk
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
2:56
#esmo22 highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. rcc: cosmic-313
-
1:56
checkmate 9er: arcc patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib
-
3:31
cabozantinib–nivolumab and ipilimumab combinations show potential for gu cancers | andrea apolo
-
3:16
cabo-nivo or cabo-nivo-ipi for metastatic genitourinary tumors
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
0:57
exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
-
0:53
carina: cabozantinib post first-line immune-oncology cpi-containing combination in arcc
-
2:34
nivo cabozantinib vs sunitinib for first-line treatment of arcc
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
2:14
managing renal cell carcinoma after progressing on checkpoint inhibitors
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials